NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/26/2026
Back to search
Official data from USPTO
RIGEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
02/27/2026
Trademark type
Combined
Nice classes
5, 16, 42, 44
Filing date
03/21/2018
Registration date
11/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2026
Last transaction
02/27/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/30/2018
First use in commerce
05/30/2018
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
CAHILL, CLARE GALLAGHER
Current location
Historical data usage
Mark description
The mark consists of the word "RIGEL" with an arc that decreases in thickness from left to right positioned above. The color white represents background and does not form part of the mark.
Holders and representatives
Holders
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Representatives
James J. Saul FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 5Class 16Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of cancerimmune disordersinflammationrare diseasesgenetic diseasesauto-immune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditionsdiseases and disorders
Class 16
printed publicationsreportsmanualsbrochuresnewsletters and leaflets in the field of medicineresearch and pharmaceuticals
Class 42
research and development of technologies and scientific data in the field of new drug development for others; Medical and scientific research in the field inflammatory disease and disordersimmune system disease and disordersmetabolic disease and disordersdermatological and hematological disease and disorderscancer and rare diseases; Providing a website featuring scientific research information related to inflammatory disease and disordersimmune system disease and disordersmetabolic disease and disorderdermatological and hematological diseases and disorderscancer and rare diseases
Class 44
Providing a website featuring information for medical professionalspharmaciesconsumers regarding therapeutic properties of pharmaceuticalsthe treatment of diseases and medical conditionsmedical information about the administration and dosing of pharmaceuticals; Providing a website featuring medical information related to inflammatory disease and disordersimmune system disease and disordersmetabolic disease and disordersdermatological and hematological disease and disorderscancer and rare diseases
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/26/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
E815
TEAS SECTION 8 & 15 RECEIVED
11/20/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/25/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/25/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/25/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/25/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/25/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/22/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/21/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/08/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/08/2019
IUAF
USE AMENDMENT FILED
09/19/2019
EISU
TEAS STATEMENT OF USE RECEIVED
09/19/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/16/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/19/2019
PUBO
PUBLISHED FOR OPPOSITION
02/19/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/30/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/02/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/02/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/02/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/18/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/20/2018
GNRT
NON-FINAL ACTION E-MAILED
06/20/2018
CNRT
NON-FINAL ACTION WRITTEN
06/20/2018
DOCK
ASSIGNED TO EXAMINER
06/12/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/29/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2018
NWAP
NEW APPLICATION ENTERED
03/24/2018
Continuous trademark protection
Get notified about every new filing that threatens RIGEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.